Chemocentryx Issuance Purchase of Equity Shares vs Issuance Repayment of Debt Securities Analysis

CCXI -  USA Stock  

USD 15.99  0.58  3.50%

Chemocentryx financial indicator trend analysis is way more than just evaluating Chemocentryx prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Chemocentryx is a good investment. Please check the relationship between Chemocentryx Issuance Purchase of Equity Shares and its Issuance Repayment of Debt Securities accounts. Continue to Trending Equities.

Issuance Purchase of Equity Shares vs Issuance Repayment of Debt Securities

Accounts Relationship

Issuance Purchase of Equity Shares vs Issuance Repayment of Debt Securities

Significance: Weak Contrarian Relationship

Issuance Purchase of Equity Shares diversification synergy
Overlapping area represents amount of trend that can be explained by analyzing historical patterns of Chemocentryx Issuance Purchase of Equity Shares account and Issuance Repayment of Debt Securities

Correlation Coefficient

-0.01
Relationship DirectionNegative 
Relationship StrengthInsignificant

Issuance Purchase of Equity Shares

A component of Net Cash Flow from Financing representing the net cash inflow (outflow) from common equity changes. Includes additional capital contributions from share issuances and exercise of stock options; and outflow from share repurchases.

Issuance Repayment of Debt Securities

A component of Net Cash Flow from Financing representing the net cash inflow (outflow) from issuance (repayment) of debt securities.
Most indicators from Chemocentryx fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Chemocentryx current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Chemocentryx Issuance Repayment of Debt Securities is most likely to in the upcoming years. The last year's value of Issuance Repayment of Debt Securities was reported at 5.01 Million
 2018 2019 2020 2021 (projected)
Interest Expense1.22 M2.15 M2.64 M2.85 M
Gross Profit42.88 M36.13 M64.89 M54.5 M

Chemocentryx fundamental ratios Correlations

-0.62-0.66-0.65-0.61-0.31-0.76-0.43-0.78-0.1-0.49-0.71-0.71-0.54-0.61-0.72-0.55-0.62-0.620.7
-0.620.980.970.90.320.960.470.95-0.220.960.980.980.220.410.420.391.01.0-0.34
-0.660.981.00.890.40.970.530.96-0.10.920.990.990.290.550.570.540.980.97-0.34
-0.650.971.00.840.410.960.530.96-0.090.90.980.990.240.590.60.580.970.96-0.33
-0.610.90.890.840.280.870.480.87-0.170.920.910.870.510.280.330.250.90.91-0.34
-0.310.320.40.410.280.460.360.480.050.180.30.30.170.610.550.630.320.3-0.08
-0.760.960.970.960.870.460.541.0-0.130.880.960.960.320.550.580.530.960.96-0.43
-0.430.470.530.530.480.360.540.560.570.320.50.490.420.660.640.660.470.450.32
-0.780.950.960.960.870.481.00.56-0.110.860.960.960.340.580.60.550.950.95-0.43
-0.1-0.22-0.1-0.09-0.170.05-0.130.57-0.11-0.31-0.11-0.110.380.40.390.41-0.22-0.250.36
-0.490.960.920.90.920.180.880.320.86-0.310.930.920.210.190.210.170.960.97-0.35
-0.710.980.990.980.910.30.960.50.96-0.110.931.00.350.50.530.470.980.97-0.42
-0.710.980.990.990.870.30.960.490.96-0.110.921.00.280.520.550.50.980.97-0.42
-0.540.220.290.240.510.170.320.420.340.380.210.350.280.30.390.250.220.22-0.26
-0.610.410.550.590.280.610.550.660.580.40.190.50.520.30.991.00.410.38-0.11
-0.720.420.570.60.330.550.580.640.60.390.210.530.550.390.990.970.420.41-0.22
-0.550.390.540.580.250.630.530.660.550.410.170.470.50.251.00.970.390.37-0.04
-0.621.00.980.970.90.320.960.470.95-0.220.960.980.980.220.410.420.391.0-0.34
-0.621.00.970.960.910.30.960.450.95-0.250.970.970.970.220.380.410.371.0-0.36
0.7-0.34-0.34-0.33-0.34-0.08-0.430.32-0.430.36-0.35-0.42-0.42-0.26-0.11-0.22-0.04-0.34-0.36
Click cells to compare fundamentals

Chemocentryx Account Relationship Matchups

Chemocentryx fundamental ratios Accounts

201620172018201920202021 (projected)
Accounts Payable671 K1.4 M966 K1.53 M12.88 M13.89 M
Accumulated Other Comprehensive Income(50 K)(119 K)(198 K)318 K114 K123 K
Total Assets155.87 M189.33 M183.31 M209.08 M518.9 M559.86 M
Current Assets148.69 M179.83 M181.38 M174.36 M441.57 M476.43 M
Assets Non Current7.18 M9.5 M1.93 M34.72 M77.33 M83.43 M
Cash and Equivalents12.02 M40.02 M28.09 M39.18 M32.3 M30.23 M
Cash and Equivalents USD12.02 M40.02 M28.09 M39.18 M32.3 M30.23 M
Shareholders Equity49.89 M79.27 M14.74 M66 M385.61 M416.06 M
Shareholders Equity USD49.89 M79.27 M14.74 M66 M385.61 M416.06 M
Investments111.74 M95.2 M148.9 M163.06 M428.07 M461.87 M
Investments Current105.74 M87.27 M148.9 M133.61 M404.27 M436.19 M
Investments Non Current5.01 M6 M7.93 M29.45 M23.8 M21.45 M
Total Liabilities105.98 M110.06 M168.57 M143.08 M133.29 M109.15 M
Current Liabilities38.34 M32.94 M64.4 M59.08 M51.56 M42.89 M
Liabilities Non Current67.65 M77.12 M104.18 M84 M81.73 M66.26 M
Trade and Non Trade Payables671 K1.4 M966 K1.53 M12.88 M13.89 M
Property Plant and Equipment Net905 K1.21 M1.54 M3.86 M52.07 M56.18 M
Accumulated Retained Earnings Deficit(307.06 M)(289.2 M)(374.5 M)(429.99 M)(485.34 M)(498.11 M)

Be your own money manager

Our tools can tell you how much better you can do entering a position in Chemocentryx without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Pair Trading with Chemocentryx

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.

Chemocentryx Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Chemocentryx and Dynavax Technologies. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Trending Equities. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.